In managing cancer therapy-related diarrhea that is refractory to standard measures, which intervention is specifically used?

Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Multiple Choice

In managing cancer therapy-related diarrhea that is refractory to standard measures, which intervention is specifically used?

When diarrhea from cancer therapies remains uncontrolled despite standard supportive care, a somatostatin analog is used to target persistent, secretory diarrhea. Octreotide works by inhibiting a range of GI secretions and slowing intestinal movement, which reduces the volume and frequency of stool. This makes it effective for chemotherapy- or radiotherapy–related diarrhea that doesn’t respond to hydration, electrolyte replacement, loperamide, or dietary changes. Typically given by subcutaneous injection (with dosing adjusted to response), octreotide can also be used in long-acting forms. Be aware of possible side effects such as fat malabsorption leading to steatorrhea, nausea, glucose intolerance or hypoglycemia, and risk of gallstones with longer use. It’s reserved for refractory cases because it’s specifically addressing the secretory component of the diarrhea that standard measures don’t control.

When diarrhea from cancer therapies remains uncontrolled despite standard supportive care, a somatostatin analog is used to target persistent, secretory diarrhea. Octreotide works by inhibiting a range of GI secretions and slowing intestinal movement, which reduces the volume and frequency of stool. This makes it effective for chemotherapy- or radiotherapy–related diarrhea that doesn’t respond to hydration, electrolyte replacement, loperamide, or dietary changes.

Typically given by subcutaneous injection (with dosing adjusted to response), octreotide can also be used in long-acting forms. Be aware of possible side effects such as fat malabsorption leading to steatorrhea, nausea, glucose intolerance or hypoglycemia, and risk of gallstones with longer use. It’s reserved for refractory cases because it’s specifically addressing the secretory component of the diarrhea that standard measures don’t control.

More practice questions